GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BSF Enterprise PLC (OTCPK:BSFAF) » Definitions » COGS-to-Revenue

BSFAF (BSF Enterprise) COGS-to-Revenue : 15.60 (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is BSF Enterprise COGS-to-Revenue?

BSF Enterprise's Cost of Goods Sold for the six months ended in Sep. 2024 was $0.08 Mil. Its Revenue for the six months ended in Sep. 2024 was $0.01 Mil.

BSF Enterprise's COGS to Revenue for the six months ended in Sep. 2024 was 15.60.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. BSF Enterprise's Gross Margin % for the six months ended in Sep. 2024 was -1,460.00%.


BSF Enterprise COGS-to-Revenue Historical Data

The historical data trend for BSF Enterprise's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BSF Enterprise COGS-to-Revenue Chart

BSF Enterprise Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
COGS-to-Revenue
Get a 7-Day Free Trial - - - 5.50 1.47

BSF Enterprise Semi-Annual Data
Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 5.50 0.48 15.60

BSF Enterprise COGS-to-Revenue Calculation

BSF Enterprise's COGS to Revenue for the fiscal year that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.113 / 0.077
=1.47

BSF Enterprise's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.078 / 0.005
=15.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BSF Enterprise  (OTCPK:BSFAF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

BSF Enterprise's Gross Margin % for the six months ended in Sep. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.078 / 0.005
=-1,460.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


BSF Enterprise COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of BSF Enterprise's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BSF Enterprise Business Description

Traded in Other Exchanges
Address
2 Portman Street, London, GBR, W1H 6DU
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.

BSF Enterprise Headlines

From GuruFocus